Baltimore, Maryland – The city health department in partnership with Emocha, a health app developer will work hand-in-hand for a medication adherence pilot.
The Electronic MObile Comprehensive Application (EMOCHA), a health application developer is working with the Baltimore department of health in running a medication adherence pilot for tuberculosis patients.
Tuberculosis patients need an urgent care near me relief, or a facility of any kind, helping them monitors and overcome their health conditions conveniently and effectively. Not all of these patients have access to urgent care clinics or facilities, and not all are capable of paying the costs of their medications or treatments.
The health department will be using Emocha’s application, the miDOT, which means Mobile Indirect Observational Therapy. The miDOT app will be used throughout the medication adherence pilot.
The said application is capable of recording videos of patients as they go through their tuberculosis medication. These patients with the disease, diagnosed by an urgent care clinic should undergo a directly observed treatment during the first 6 months of their therapy. All participants of the program will make use of the miDOT app.
Additionally, the recorded videos will be forwarded to the patients’ physicians. The health app will likewise assist the patients in monitoring their symptoms through a daily clinical assessment.
Doctor Patrick Chaulk, the acting deputy commissioner for communicable disease of Baltimore City, said, the app will boost the city health department’s capabilities in providing quality care and treatment for tuberculosis patients. Dr. Chaulk pointed out that the health app will also free up the clinician time required for other critical tuberculosis control activities.
In 2008, the Johns Hopkins Center for Clinical Global Health Applications originally developed the Emocha, seeing the need for convenient and urgent care for a wide array of health patients. However, it spun off later in 2013 into its own company. The creation of the Emocha software was basically designed to help researchers, providers, health programs, and patients in the overall improvement of data collection, communication, and patient care.
The Baltimore health department will utilize the software free of charge, based on the Baltimore Business Journal report. Sebastian Seiguer, the Chief Executive Officer (CEO) of the application developer said the experimental program will be a good move as it will support Emocha in obtaining its product validation. Thus, both agencies are expecting for positive results throughout the medication adherence pilot, providing tuberculosis patients the quality health care that they need.
